Dunja Jakovljevic
Research Subjects
Research Interests
Dunja Jakovljevic has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Iva Barjaktarovic
University of Novi Sad, Faculty of Medicine, Department of General Education Subjects, Novi Sad, Serbia + University Clinical Center of Vojvodina, Center for Laboratory Diagnostics, Novi Sad, Serbia
2 shared publications - Ljuba Vujanović
University of Novi Sad, Faculty of Medicine, Department of Dermatovenereology, Novi Sad, Serbia + University Clinical Center of Vojvodina, Clinic of Dermatovenereology Diseases, Novi Sad, Serbia
2 shared publications - Olivera Levakov
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
2 shared publications - Sanja Jakovljevic
University of Novi Sad, Faculty of Medicine, Department of Dermatovenereology, Novi Sad, Serbia + University Clinical Center of Vojvodina, Clinic of Dermatovenereology Diseases, Novi Sad, Serbia
2 shared publications
Latest Publications
- Open Access
- 23 October 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (11) , 192
miRNA-146-a, miRNA-21, miRNA-143, miRNA-29-b and miRNA-223 as Potential Biomarkers for Atopic Dermatitis
Background/Objectives: Recently, epigenetic mechanisms have been recognized as crucial in atopic dermatitis development. The emphasis of this research was on expanding existing knowledge about the epigenetic aspects of atopic dermatitis, as well as identifying new molecules that could serve as disease biomarkers. Methods: The research was conducted as a cross-sectional study examining two groups: the group with atopic dermatitis (50 patients) and the control group (50 healthy adults). The serum levels of total immunoglobulin E (IgE) and eosinophil count (Eos%) were performed in routine laboratory analyses, and the detection of microRNAs from peripheral blood was performed using RT-PCR. Results: Analysis of selected miRNA expressions in patients with atopic dermatitis and controls revealed that only the expression and the relative expression of miRNA-146a were statistically significantly higher in patients with atopic dermatitis than in the control group (p = 0.042 and p = 0.021, respectively). There was a weak positive correlation between miRNA-146a expression and the eosinophilia/IgE level (r = 0.22 and r = 0.25, respectively). MiRNA-21, miRNA-29b, miRNA-143 and miRNA-223 were significantly upregulated in patients with higher SCORAD (p < 0.001, p < 0.001, p < 0.001 and p = 0.015, respectively). ROC curve analysis revealed the specificity of miRNA-146a as 82% and the sensitivity as 62%. The area under the ROC curve (AUC) was 0.7, indicating its diagnostic potential. Conclusions: Our findings imply that miRNA-146a might serve as a biomarker of atopic dermatitis, suggesting its relevance in the development of the disease, while miRNA-21, miRNA-29b, miRNA-143 and miRNA-223 may have an impact on disease progression. Our findings provide a preliminary basis that should precede validation through larger, multicentric studies and use in diagnostics, targeted personalized treatments and monitoring of treatment efficacy in atopic dermatitis.
- 23 October 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (11) , 192
Open AccessmiRNA-146-a, miRNA-21, miRNA-143, miRNA-29-b and miRNA-223 as Potential Biomarkers for Atopic Dermatitis
Background/Objectives: Recently, epigenetic mechanisms have been recognized as crucial in atopic dermatitis development. The emphasis of this research was on expanding existing knowledge about the epigenetic aspects of atopic dermatitis, as well as identifying new molecules that could serve as disease biomarkers. Methods: The research was conducted as a cross-sectional study examining two groups: the group with atopic dermatitis (50 patients) and the control group (50 healthy adults). The serum levels of total immunoglobulin E (IgE) and eosinophil count (Eos%) were performed in routine laboratory analyses, and the detection of microRNAs from peripheral blood was performed using RT-PCR. Results: Analysis of selected miRNA expressions in patients with atopic dermatitis and controls revealed that only the expression and the relative expression of miRNA-146a were statistically significantly higher in patients with atopic dermatitis than in the control group (p = 0.042 and p = 0.021, respectively). There was a weak positive correlation between miRNA-146a expression and the eosinophilia/IgE level (r = 0.22 and r = 0.25, respectively). MiRNA-21, miRNA-29b, miRNA-143 and miRNA-223 were significantly upregulated in patients with higher SCORAD (p < 0.001, p < 0.001, p < 0.001 and p = 0.015, respectively). ROC curve analysis revealed the specificity of miRNA-146a as 82% and the sensitivity as 62%. The area under the ROC curve (AUC) was 0.7, indicating its diagnostic potential. Conclusions: Our findings imply that miRNA-146a might serve as a biomarker of atopic dermatitis, suggesting its relevance in the development of the disease, while miRNA-21, miRNA-29b, miRNA-143 and miRNA-223 may have an impact on disease progression. Our findings provide a preliminary basis that should precede validation through larger, multicentric studies and use in diagnostics, targeted personalized treatments and monitoring of treatment efficacy in atopic dermatitis.
- Open Access
- 17 September 2025
- Published by MDPI AG in Preprints.org
miRNA-146-a, miRNA-21, miRNA-143, miRNA-29-b and miRNA-223 as Potential Biomarkers for Atopic Dermatitis
Background/Objectives: Recently, epigenetic mechanisms have been recognized as crucial in atopic dermatitis development. The emphasis of this research was on ex-panding existing knowledge about the epigenetic aspects of atopic dermatitis, as well as identifying new molecules that could serve as disease biomarkers. Methods: The re-search was conducted as a prospective study examining two groups: the group with atopic dermatitis (50 patients) and the control group (50 healthy adults). The serum levels of total immunoglobulin E (IgE) and eosinophil count (Eos%) were done in rou-tine laboratory analyses, and the detection of microRNAs from peripheral blood was performed using RT-PCR. Results: Analysis of selected miRNA expression in patients with atopic dermatitis and controls revealed that only the expression and the relative expression of miRNA-146a were statistically significantly higher in patients with atopic dermatitis than in the control group (p=0.042 and p=0.021, respectively). There was a weak positive correlation between miRNA-146a expression and the eosinophilia / IgE level (r=0.22 and r=0.25, respectively). The miRNA-21, miRNA-29b, miRNA-143 and miRNA-223 were significantly upregulated in patients with higher SCORAD (p< 0.001, p< 0.001, p< 0.001 and p= 0.015, respectively). ROC curve analysis revealed the specificity of miRNA-146a as 82% and the sensitivity as 62%. The area under the ROC curve (AUC) was 0.7, confirming a valid diagnostic potential. Conclusions: Our find-ings imply that miRNA-146a may be a novel biomarker of atopic dermatitis and might play a specific role in the development of the disease, while miRNA-21, miRNA-29b and miRNA-223 may have an impact on the disease progression. Our study provides findings that can be utilized in future diagnostic applications, targeted personalized treatments and support the monitoring of atopic dermatitis treatment effectiveness.
- 17 September 2025
- Published by MDPI AG in Preprints.org
Open AccessmiRNA-146-a, miRNA-21, miRNA-143, miRNA-29-b and miRNA-223 as Potential Biomarkers for Atopic Dermatitis
Background/Objectives: Recently, epigenetic mechanisms have been recognized as crucial in atopic dermatitis development. The emphasis of this research was on ex-panding existing knowledge about the epigenetic aspects of atopic dermatitis, as well as identifying new molecules that could serve as disease biomarkers. Methods: The re-search was conducted as a prospective study examining two groups: the group with atopic dermatitis (50 patients) and the control group (50 healthy adults). The serum levels of total immunoglobulin E (IgE) and eosinophil count (Eos%) were done in rou-tine laboratory analyses, and the detection of microRNAs from peripheral blood was performed using RT-PCR. Results: Analysis of selected miRNA expression in patients with atopic dermatitis and controls revealed that only the expression and the relative expression of miRNA-146a were statistically significantly higher in patients with atopic dermatitis than in the control group (p=0.042 and p=0.021, respectively). There was a weak positive correlation between miRNA-146a expression and the eosinophilia / IgE level (r=0.22 and r=0.25, respectively). The miRNA-21, miRNA-29b, miRNA-143 and miRNA-223 were significantly upregulated in patients with higher SCORAD (p< 0.001, p< 0.001, p< 0.001 and p= 0.015, respectively). ROC curve analysis revealed the specificity of miRNA-146a as 82% and the sensitivity as 62%. The area under the ROC curve (AUC) was 0.7, confirming a valid diagnostic potential. Conclusions: Our find-ings imply that miRNA-146a may be a novel biomarker of atopic dermatitis and might play a specific role in the development of the disease, while miRNA-21, miRNA-29b and miRNA-223 may have an impact on the disease progression. Our study provides findings that can be utilized in future diagnostic applications, targeted personalized treatments and support the monitoring of atopic dermatitis treatment effectiveness.